Actinium Pharmaceuticals (ATNM) Earnings Date & Reports

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ATNM is expected to report earnings to fall 9.52% to -37 cents per share on May 12

Actinium Pharmaceuticals ATNM Stock Earnings Reports

Q1'25

Est.

$-0.38

Q4'24

Missed

by $0.05

Q3'24

Est.

$-0.37

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.06

The last earnings report on March 14 showed earnings per share of -41 cents, missing the estimate of -37 cents. With 308.61K shares outstanding, the current market capitalization sits at 40.24M.

View a ticker or compare two or three

Compare

ATNM